LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Fourteen cases of acute invasive fungal rhinosinusitis: is there a place for less aggressive surgical treatment?

    Sideris, Giorgos / Arvaniti, Antonia / Giotakis, Evaggelos / Maragoudakis, Pavlos / Delides, Alexander

    Oral and maxillofacial surgery

    2022  Volume 28, Issue 1, Page(s) 157–162

    Abstract: Purpose: Acute invasive fungal rhinosinusitis (AIFRS) is a rare, fulminant, angio-invasive infection with high mortality rate. Treatment of AIFRS includes aggressive surgical debridement combined with antifungal agents and treatment of the underlying ... ...

    Abstract Purpose: Acute invasive fungal rhinosinusitis (AIFRS) is a rare, fulminant, angio-invasive infection with high mortality rate. Treatment of AIFRS includes aggressive surgical debridement combined with antifungal agents and treatment of the underlying disease. The aim of this study is to report our experience with this often fatal disease and estimate the long-term survival of AIFRS patients with more conservative surgery.
    Methods: A retrospective study was performed on immunocompromised adults with AIFRS from January 2011 to December 2020. The diagnosis was histologically confirmed by tissue fungus invasion. We analyze epidemiological and microbiological findings, the underlying disease and discuss our patients' treatment plan and long-term survival.
    Results: Fourteen patients were included in the study. Mean age was 53.8 ± 18.9 years. The underlying disease was hematologic malignancy in nine patients, diabetes mellitus in three, aplastic anemia in one, and renal/liver failure in one. Leukopenia was not significantly correlated with outcome or survival. Histological and culture findings revealed that Mucor/Rhizopus were the causative organisms in nine cases. All patients received systemic antifungal therapy. Surgery was performed in nine patients (endoscopic for all patients, combined in three with an external approach). Overall survival was 35.7% as five patients survived, two who underwent surgery, and three who were treated non-surgically. Nine patients died, two from AIFRS after central nervous system involvement and seven from their primary disease, free of fungi. Older individuals and patients with hematologic malignancies had a worse outcome.
    Conclusion: Early surgical debridement, antifungal agents, and treatment of the underlying disease remain the cornerstones of AIFRS management. Prognosis is overall defined by the underlying disease and in some selected cases, medical treatment alone could be a reasonable option.
    MeSH term(s) Adult ; Humans ; Middle Aged ; Aged ; Antifungal Agents/therapeutic use ; Rhinitis/drug therapy ; Rhinitis/surgery ; Retrospective Studies ; Rhinosinusitis ; Sinusitis/surgery ; Sinusitis/diagnosis ; Acute Disease
    Chemical Substances Antifungal Agents
    Language English
    Publishing date 2022-10-06
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2406731-3
    ISSN 1865-1569 ; 1865-1550
    ISSN (online) 1865-1569
    ISSN 1865-1550
    DOI 10.1007/s10006-022-01120-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications.

    Economopoulou, Panagiota / Perisanidis, Christos / Giotakis, Evaggelos I / Psyrri, Amanda

    Annals of translational medicine

    2016  Volume 4, Issue 9, Page(s) 173

    Abstract: Head and neck squamous cell carcinoma (HNSCC) carries a poor prognosis, with low survival rates for advanced stage tumors and minimal improvement in survival trends through the past decades. It is becoming increasingly clear that HNSCC oncogenesis and ... ...

    Abstract Head and neck squamous cell carcinoma (HNSCC) carries a poor prognosis, with low survival rates for advanced stage tumors and minimal improvement in survival trends through the past decades. It is becoming increasingly clear that HNSCC oncogenesis and evolution is characterized by profound immune defects, as cancer cells evade immunosurveillance due to accumulation of genetic mutations and tumor heterogeneity. Improved understanding of the role of the immune system in cancer has led to the identification of novel therapeutic targets, which are being investigated for their potential to provide durable responses. In this review, we will summarize the role of the immune system in HNSCC, the rationale behind immunotherapy strategies and their clinical applications.
    Language English
    Publishing date 2016-02-24
    Publishing country China
    Document type Journal Article ; Review
    ZDB-ID 2893931-1
    ISSN 2305-5847 ; 2305-5839
    ISSN (online) 2305-5847
    ISSN 2305-5839
    DOI 10.21037/atm.2016.03.34
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top